High Tower Advisors, LLC Nephros Inc Transaction History
High Tower Advisors, LLC
- $84.5 Billion
- Q3 2025
A detailed history of High Tower Advisors, LLC transactions in Nephros Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 55,710 shares of NEPH stock, worth $245,124. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,710
Previous 55,876
0.3%
Holding current value
$245,124
Previous $228,000
15.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEPH
# of Institutions
24Shares Held
4.42MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.62MShares$15.9 Million2.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA281KShares$1.24 Million0.0% of portfolio
-
Bard Associates Inc Chicago, IL127KShares$559,3320.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny82.5KShares$363,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA75.9KShares$333,9200.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $45.4M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...